---
title: "Roche Holding AG (RHHVF.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RHHVF.US.md"
symbol: "RHHVF.US"
name: "Roche Holding AG"
industry: "Pharmaceuticals"
datetime: "2026-05-20T14:41:24.609Z"
locales:
  - [en](https://longbridge.com/en/quote/RHHVF.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RHHVF.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RHHVF.US.md)
---

# Roche Holding AG (RHHVF.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.roche.com](https://www.roche.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: B (0.35)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 189 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 10.62% |  |
| Net Profit YoY | 69.52% |  |
| P/B Ratio | 8.13 |  |
| Dividend Ratio | 3.03% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 346929406176.00 |  |
| Revenue | 77820010863.80 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 39.29% | A |
| Profit Margin | 20.33% | A |
| Gross Margin | 74.49% | A |
| Revenue YoY | 10.62% | B |
| Net Profit YoY | 69.52% | A |
| Total Assets YoY | 12.85% | B |
| Net Assets YoY | 19.50% | A |
| Cash Flow Margin | 146.37% | B |
| OCF YoY | 10.62% | B |
| Turnover | 0.63 | B |
| Gearing Ratio | 62.38% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Roche Holding AG",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "10.62%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "69.52%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "8.13",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "3.03%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "346929406176.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "77820010863.80",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "39.29%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "20.33%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "74.49%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "10.62%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "69.52%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.85%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "19.50%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "146.37%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "10.62%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.63",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "62.38%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 21.93 | 39/189 | 29.51 | 26.13 | 23.54 |
| PB | 8.13 | 174/189 | 9.33 | 8.07 | 7.47 |
| PS (TTM) | 4.46 | 96/189 | 4.72 | 4.15 | 3.69 |
| Dividend Yield | 3.03% | 10/189 | 3.59% | 3.24% | 2.92% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-23T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 417.00 |
| Highest Target | 484.20 |
| Lowest Target | 484.20 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/RHHVF.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/RHHVF.US/norm.md)
- [Related News](https://longbridge.com/en/quote/RHHVF.US/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**